No. This is not a requirement for INDs. We don't submit a 32P82 section. But the protocol for your development/clinical batches should be presented in 32P81.
------------------------------
Tom Stothoff
Senior Director, Regulatory Affairs CMC
Chicago
------------------------------
Original Message:
Sent: 09-Dec-2022 18:27
From: Hua Jin
Subject: 3.2.P.8.2 Post-approval Stability Protocol and Stability Commitment
Dear community,
For IND, does the sponsor needs to write anything in M 3.2.P.8.2 Post-approval Stability Protocol and Stability Commitment?
Thank you.
------------------------------
Hua Jin
United States
------------------------------